Loading...
Last update:  May 26, 2023
08:28 +1GMT

Allergenic Molecule  Dau c 1Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
5.1.1 - Source Exposed (Symptoms)2005SwitzerlandIgE4097.500
5.7.2 - Source Exposed (Provocation Test - Ingestion)2012SwitzerlandIgE2095.00020120410, Ballmer-Weber BK
5.2.1 - Source Exposed (Symptoms, SPT)2005GermanyIgE2075.000
5.7.2 - Source Exposed (Provocation Test - Ingestion)2012DenmarkIgE2070.00020120410, Ballmer-Weber BK
5.2.1 - Source Exposed (Symptoms, SPT)2005GermanyHRT2065.000
5.7.2 - Source Exposed (Provocation Test - Ingestion)2012SpainIgE944.00020120410, Ballmer-Weber BK
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2005SwitzerlandIgE2138.100
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012DenmarkIgE3030.00020120410, Ballmer-Weber BK
4.1.6 - Heterologous Source Sensitized (High IgE)2011AustriaIgE6028.33020110211, DAvino R
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE2025.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012SwitzerlandIgE2124.00020120410, Ballmer-Weber BK
4.1.6 - Heterologous Source Sensitized (High IgE)2011ItalyIgE21420.09020110211, DAvino R
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE3713.51020090826, Ebo DG
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2010.00020091005, Ott H
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2010.00020091005, Ott H
4.1.5 - Heterologous Source Sensitized (IgE)2011ItalyIgE10846.82020110211, DAvino R
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE996.06020110223, De Knop KJ
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE1401.43020130111, Ott H
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE961.04020120528, Patelis A
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE164080.36020100301, Scala E
1.3 - Rhinitis, Diagnosed2013BrazilIgE1010.00020130912, Lacerda Araujo LM
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE220.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012SpainIgE200.00020120410, Ballmer-Weber BK
6.2 - General Population (Adults)2012SwedenIgE3710.00020120528, Patelis A
Developed by
Panservice